Align Technology | ALGN - Ebitda




Align Technology reported $218.66M in EBITDA for its fiscal quarter ending in December of 2024.

Ebitda Change Date
3M USD 1.47B 841M Dec/2024
Align Technology USD 218.66M 51.8M Dec/2024
Becton, Dickinson and Co. USD 1.25B 503M Dec/2024
Bruker USD 161.7M 29.3M Dec/2024
Cardinal Health USD 758M 3M Dec/2024
Charles River Laboratories USD 192.3M 43.95M Dec/2024
Cooper Companies USD 262.7M 18.8M Oct/2024
CVS Health USD 3.58B 358M Dec/2024
Danaher USD 2.02B 365M Dec/2024
Dentsply International USD -371000000 508M Sep/2024
Dexcom USD 237.4M 7.3M Sep/2024
Henry Schein USD 279M 41M Sep/2024
Idexx Laboratories USD 338.02M 38.68M Sep/2024
Insulet USD 109.4M 28.1M Sep/2024
Integra LifeSciences USD 34.97M 5.27M Sep/2024
IQVIA Holdings USD 856M 12M Sep/2024
Masimo USD 88.6M 33.8M Sep/2024
McKesson USD 1.4B 162M Dec/2024
Mettler Toledo International USD 365.41M 54.15M Dec/2024
Patterson Companies USD 70.23M 9.7M Oct/2024
Revvity USD 215.64M 4.12M Dec/2024
Solventum Corp 408M 31M Sep/2024
Stryker USD 1.98B 541M Dec/2024
Teleflex USD 212.82M 26.03M Sep/2024
Thermo Fisher Scientific USD 2.99B 149M Dec/2024
Veeva Systems USD 191.28M 13.78M Oct/2024
Walgreens Boots Alliance USD 870M 2.19B Nov/2024
Waters USD 343.66M 81.1M Dec/2024
Zimmer Biomet Holdings USD 723.1M 149.6M Dec/2024
Zoetis USD 822M 217M Dec/2024